Cotargeting EGFR and IKKNFB signalling pathways in head and neck squamous cell carcinoma a potential novel therapy for head and neck squamous cell cancer

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer

22:14 EST 25 Dec 2018 | Nature Publishing

More From BioPortfolio on "Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer"